Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 51, Issue 4, Pages 693-697Publisher
SPRINGER
DOI: 10.1007/s10620-006-3193-0
Keywords
peroxisome proliferator-activated receptor gamma (PPAR gamma); Toll-like receptor; HT-29
Categories
Ask authors/readers for more resources
The peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor highly expressed in the colon and playing an anti-inflammatory role through inhibition of the NF-kappa B pathway. Toll-like receptor 4 (TLR4) has been known to mediate LPS-induced cellular signaling through activation of NF-kappa B pathway in intestinal epithelial cells. The aims of this study were to evaluate attenuation of inflammation by PPAR gamma in intestinal epithelial cells and to study the possible relation between PPAR gamma and TLR4. HT-29 human epithelial cells were stimulated with LPS (20 mu g/ml) and PPAR gamma ligand, 15d-PGJ(2) (10 mu M), or with LPS (20 mu g/ml) alone for 24 hr. COX-2, IL-8, TLR4, and PPAR gamma mRNA expression was assessed by RT-PCR. IL-8 protein levels and TLR4 protein expression were analyzed by ELISA and Western blot, respectively. To evaluate the action mechanisms of PPAR gamma ligand, Western blot analysis for I kappa B alpha degradation was performed. Costimulation with LPS and PPAR gamma ligand in comparison to LPS stimulation alone (1) decreased COX-2, IL-8 mRNA expression and IL-8 protein secretion, (2) decreased TLR4 mRNA and protein expression, and (3) decreased PPAR gamma mRNA expression. PPAR gamma ligand delayed LPS-induced I kappa B alpha degradation. These findings suggest that PPAR-gamma ligands suppress inflammation in intestinal epithelial cells. PPAR gamma and TLR, these two antagonistic signaling pathways in intestinal epithelial cells may be partially cross-linked.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available